Redsense Medical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Pontus Nobreus

Chief executive officer

kr745.0k

Total compensation

CEO salary percentage100.0%
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure1.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Pontus Nobreus's remuneration changed compared to Redsense Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-kr8m

Dec 31 2023n/an/a

-kr5m

Sep 30 2023n/an/a

-kr6m

Jun 30 2023n/an/a

-kr8m

Mar 31 2023n/an/a

-kr7m

Dec 31 2022kr745kkr745k

-kr9m

Compensation vs Market: Pontus's total compensation ($USD70.79K) is below average for companies of similar size in the German market ($USD396.66K).

Compensation vs Earnings: Insufficient data to compare Pontus's compensation with company performance.


CEO

Pontus Nobreus (59 yo)

1.8yrs

Tenure

kr745,000

Compensation

Mr. Pontus Nobreus serves as Chief Executive Officer of Redsense Medical AB (publ) since August 01, 2022. Mr. Nobreus served as Chief Executive Officer at Glycorex Transplantation AB (publ) since October 1...


Leadership Team

NamePositionTenureCompensationOwnership
Pontus Nobreus
Chief Executive Officer1.8yrskr745.00kno data
Jennie Kardell
Chief Financial Officer1.2yrsno datano data
Sebastien Bollue
Chief Operating Officer8.3yrsno datano data
Ann-Marie Eriksson
Chief Technology Officer4.3yrsno datano data

3.0yrs

Average Tenure

Experienced Management: R0Z's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Susanne Olauson
Director11.3yrskr75.00kno data
Eva Walde
Chairmanless than a yearno datano data
Malin Almgren
Director1.3yrsno datano data
Lena Oswald
Director1.3yrsno datano data

1.3yrs

Average Tenure

53yo

Average Age

Experienced Board: R0Z's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.